Drug licence suspension proposal 2026 is an important regulatory development for India’s pharmaceutical industry. The Ministry of Health and Family Welfare has proposed amendments to the Drugs Rules, 1945, that could allow immediate suspension of a drug manufacturing licence following specified critical quality failures reported by a Government Analyst. The proposal focuses on Not of […]
Last Updated: 3 November 2026 The CDSCO high-risk solvents 2026 regulatory update is an important development for India’s pharmaceutical manufacturing and quality control sector. The Central Drugs Standard Control Organisation (CDSCO) has reinforced digital monitoring of high-risk pharmaceutical-grade solvents through the Online National Drugs Licensing System (ONDLS), requiring batch-wise information and digital clearance before distribution […]
Last Updated: 3 November 2026 Generic oral semaglutide in India is becoming an important development in the pharmaceutical industry. On 31 October 2026, Sun Pharmaceutical Industries reportedly received CDSCO approval for its generic oral semaglutide tablets in 3 mg, 7 mg and 14 mg strengths for the treatment of type 2 diabetes mellitus. This development […]
Last updated: 3 October 2026 If you are searching for the Schedule H1 drugs list 2026, there is an important point to understand first: Schedule H1 is not simply an “antibiotics list.” It is a specific regulatory category under the Drugs Rules, 1945, containing medicines that are subject to additional prescription and record-keeping requirements. As […]
AI-generated prescriptions ban debate in India has become one of the biggest regulatory controversies in the Indian pharmaceutical sector in 2026. The debate began after reports revealed that AI-generated fake medical prescriptions were allegedly being accepted by certain online pharmacy platforms, raising serious concerns about patient safety, prescription verification, and drug regulation. Over 12 lakh […]
The cough syrup prescription rule India 2026 marks one of the biggest regulatory changes in Indian pharmacy practice. Under the Drugs (Fifth Amendment) Rules, 2026, cough syrups can no longer be sold over the counter and now require a valid medical prescription. From June 2026, every cough syrup in India has moved from “grab it […]
